Seeking Alpha

Alexza Pharmaceuticals (ALXA +24%) soaring premarket as it resubmits its application for...

Alexza Pharmaceuticals (ALXA +24%) soaring premarket as it resubmits its application for Adasuve, a schizophrenic and bipolar disorder treatment. A previous FDA letter suggested a manufacturing deficiency needed to be resolved, but seemed to flag no other concerns for the drug.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)